Neovascand Boston Scientific Close US$75 Million.

Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities ‒ $75M transaction enhances manufacturing expertise in structural heart ‒ Includes 15% equity investment in Neovasc. 2016/12/13 · Neovasc and Boston Scientific Close US$75 Million Agreement News provided by Neovasc Inc. Dec 13, 2016, 07:00 ET Share this article.

2016/12/13 · The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire Neovasc's advanced biologic tissue capabilities and certain manufacturing assets and make a 15% equity investment in. A copy of the report to be filed by Boston Scientific in connection with the transactions will be available on the Neovasc SEDAR profile at, and can also be obtained by contacting Investor Relations at Boston, is a. 2016/12/13 · Neovasc Inc. "Neovasc" or the "Company" NVCN, 3.29% NVC today announced the. The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire Neovasc's advanced biologic tissue capabilities and certain manufacturing assets and make a 15% equity investment in Neovasc, for a total of US$75 million in cash. 2016/02/12 · MARLBOROUGH, Mass., Dec. 2, 2016 /PRNewswire/ -- Boston Scientific Corporation NYSE: BSX today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc.

Concurrently, Boston Scientific has committed to invest an additional US$7,090,200 in Neovasc for a 15% equity interest in the Company. "Boston Scientific has been a long-term customer of Neovasc, having historically represented a sizeable percentage of our tissue processing revenues," commented Neovasc CEO, Alexei Marko. Boston Scientific has agreed to pay approximately $67.9 million for Neovasc's tissue processing technology and facility and will invest approximately $7.1 million in the company, according to a Neovasc.

Prior to Neovasc, Aaron has served in various roles, including management roles within Research & Development and support of Manufacturing activities at Oakriver Technology, Boston Scientific and St. Jude Medical. In addition to.